US FDA asks to not purchase certain eye drops due to infection risk (updated)

Rite Aid

28/10/2023 24:28

(Recast with details from FDA statement)
       Oct 27 (Reuters) - The U.S. Food and Drug Administration
on Friday issued a warning to consumers to not purchase or use
certain eye drops from several major brands due to the risk of
eye infection.
    The agency warned against the use of 26 over-the-counter eye
drop products and said using them could result in partial vision
loss or blindness.    
    The eye drops are marketed by CVS Health  CVS.N , Rite Aid
 RADCQ.PK  Cardinal Health  CAH.N  along with Target's  TGT.N 
up & up brand and Velocity Pharma, the FDA said in a statement.
It has also asked the manufacturer to recall all lots of the
product.
    CVS, Rite Aid and Target are removing the products from
their store shelves and websites, according to the FDA. It also
said that products branded as Leader, Rugby and Velocity may
still be available to purchase in stores and online and advised
against purchasing them. 
     FDA recommended consumers to properly discard these
products, and advised patients who have signs or symptoms of an
eye infection after using these products to talk to their health
care provider or seek medical care immediately. 
    
    
    
        
  

 (Reporting by Mrinmay Dey in Bengaluru; Editing by Leslie Adler
and Shri Navaratnam)
 ((Mrinmay.Dey@thomsonreuters.com;))